PFIZER INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
- Conditions
- Diastolic Heart Failure
- Interventions
- Drug: PlaceboDrug: Sitexsentin sodium
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 200
- Registration Number
- NCT00303498
- Locations
- ๐บ๐ธ
Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston, Massachusetts, United States
๐บ๐ธBrigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธAlbert Einstein Medical Center, Philadelphia, Pennsylvania, United States
Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy
- Conditions
- Arthritis, Psoriatic, Psoriasis
- First Posted Date
- 2006-03-15
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 107
- Registration Number
- NCT00303186
- Locations
- ๐ฎ๐น
Pfizer Investigational Site, Roma, Italy
To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00300677
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Belmont, Massachusetts, United States
Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 119
- Registration Number
- NCT00299494
- Locations
- ๐บ๐ธ
Emory University Hospital, Atlanta, Georgia, United States
๐บ๐ธFox Chase Cancer Center, Philadelphia, Pennsylvania, United States
๐บ๐ธNorthwestern Medical Faculty Foundation, Chicago, Illinois, United States
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
- Conditions
- Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
- Interventions
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 129
- Registration Number
- NCT00293709
- Locations
- ๐ฉ๐ช
Pfizer Investigational Site, Muenchen, Germany
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
- Conditions
- Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
- Interventions
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1308
- Registration Number
- NCT00293722
- Locations
- ๐ฉ๐ช
Pfizer Investigational Site, Toerwang-Samerberg, Germany
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer
- First Posted Date
- 2006-02-14
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 22
- Registration Number
- NCT00291577
- Locations
- ๐ธ๐ช
Pfizer Investigational Site, Stockholm, Sweden
Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
- Conditions
- Antifungal Prophylaxis of Invasive Fungal Infections
- Interventions
- First Posted Date
- 2006-02-10
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 489
- Registration Number
- NCT00289991
- Locations
- ๐ฌ๐ง
Pfizer Investigational Site, Manchester, United Kingdom
[S,S]-Reboxetine Dose-Range Finding Trial
- Conditions
- Pain
- First Posted Date
- 2006-02-08
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 280
- Registration Number
- NCT00288652
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Tacoma, Washington, United States
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
- Conditions
- Invasive Fungal Infections
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2008-06-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 77
- Registration Number
- NCT00288197
- Locations
- ๐จ๐ณ
Pfizer Investigational Site, Tianjin, China